Harpoon Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Harpoon Therapeutics, Inc.‘s stocks are currently a part of 46 hedge funds’ portfolios, which represents 57.07% of the total amount of its stocks outstanding. This makes up a total of 18.86M shares of Harpoon Therapeutics, Inc.. Compared to the previous quarter, the number fell by -12.98% or -2.81M shares fewer. As for the holding position changes, 15.22% (7) of current hedge fund investors increased the number of shares held, 30.43% (14) of current holders sold a part of the shares held, and 30.43% (14) closed the holdings completely. 17 hedge funds are new holders of Harpoon Therapeutics, Inc. stock in Q4 2022, it is 36.96% of total holders.
Hedge funds holding Harpoon Therapeutics (Q1 2019 – Q4 2022)
Q1 2019 | 29 |
---|---|
Q2 2019 | 32 |
Q3 2019 | 42 |
Q4 2019 | 50 |
Q1 2020 | 51 |
Q2 2020 | 69 |
Q3 2020 | 79 |
Q4 2020 | 76 |
Q1 2021 | 88 |
Q2 2021 | 85 |
Q3 2021 | 88 |
Q4 2021 | 80 |
Q1 2022 | 73 |
Q2 2022 | 54 |
Q3 2022 | 43 |
Q4 2022 | 46 |
Hedge funds changes in Harpoon Therapeutics positions (Q1 2019 – Q4 2022)
Q1 2019 | 29 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q2 2019 | 6 | 15 | 2 | 3 | 6 |
Q3 2019 | 11 | 20 | 2 | 1 | 8 |
Q4 2019 | 13 | 21 | 6 | 5 | 5 |
Q1 2020 | 11 | 22 | 9 | 10 | -1 |
Q2 2020 | 23 | 24 | 13 | 5 | 4 |
Q3 2020 | 18 | 24 | 21 | 8 | 8 |
Q4 2020 | 12 | 24 | 19 | 15 | 6 |
Q1 2021 | 24 | 35 | 20 | 12 | -3 |
Q2 2021 | 11 | 39 | 28 | 14 | -7 |
Q3 2021 | 20 | 22 | 33 | 17 | -4 |
Q4 2021 | 16 | 27 | 19 | 23 | -5 |
Q1 2022 | 13 | 20 | 24 | 20 | -4 |
Q2 2022 | 11 | 11 | 21 | 29 | -18 |
Q3 2022 | 3 | 9 | 16 | 14 | 1 |
Q4 2022 | 17 | 7 | 14 | 14 | -6 |
Hedge funds changes in Harpoon Therapeutics stock options (Q1 2019 – Q4 2022)
Q1 2019 | 0 | 0 |
---|---|---|
Q2 2019 | 0 | 0 |
Q3 2019 | 0 | 0 |
Q4 2019 | 0 | 0 |
Q1 2020 | 0 | 0 |
Q2 2020 | 0 | 0 |
Q3 2020 | 762,000 | 1,049,000 |
Q4 2020 | 674,000 | 2,724,000 |
Q1 2021 | 2,084,000 | 3,004,000 |
Q2 2021 | 1,545,000 | 1,895,000 |
Q3 2021 | 659,000 | 687,000 |
Q4 2021 | 463,000 | 457,000 |
Q1 2022 | 193,000 | 185,000 |
Q2 2022 | 57,000 | 19,000 |
Q3 2022 | 18,000 | 10,000 |
Q4 2022 | 29,399 | 7,459 |